nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—CHRM1—schizophrenia	0.155	0.198	CbGaD
Minaprine—MAOA—schizophrenia	0.128	0.163	CbGaD
Minaprine—DRD1—schizophrenia	0.116	0.148	CbGaD
Minaprine—HTR2C—schizophrenia	0.0994	0.127	CbGaD
Minaprine—SLC6A4—schizophrenia	0.0823	0.105	CbGaD
Minaprine—DRD2—schizophrenia	0.0819	0.105	CbGaD
Minaprine—HTR2A—schizophrenia	0.0633	0.0808	CbGaD
Minaprine—CYP2D6—schizophrenia	0.0579	0.0739	CbGaD
Minaprine—MAOA—locus ceruleus—schizophrenia	0.00531	0.0767	CbGeAlD
Minaprine—DRD1—telencephalic ventricle—schizophrenia	0.00422	0.0608	CbGeAlD
Minaprine—HTR2A—locus ceruleus—schizophrenia	0.00346	0.05	CbGeAlD
Minaprine—HTR2C—telencephalic ventricle—schizophrenia	0.00328	0.0473	CbGeAlD
Minaprine—HTR2A—cerebellar cortex—schizophrenia	0.00282	0.0408	CbGeAlD
Minaprine—DRD2—telencephalic ventricle—schizophrenia	0.00249	0.0359	CbGeAlD
Minaprine—HTR2A—pons—schizophrenia	0.002	0.0288	CbGeAlD
Minaprine—HTR2A—autonomic nervous system—schizophrenia	0.00184	0.0266	CbGeAlD
Minaprine—HTR2A—telencephalic ventricle—schizophrenia	0.00164	0.0237	CbGeAlD
Minaprine—HTR2A—urine—schizophrenia	0.0015	0.0217	CbGeAlD
Minaprine—SLC6A4—blood plasma—schizophrenia	0.00148	0.0214	CbGeAlD
Minaprine—HTR2A—pineal body—schizophrenia	0.00143	0.0206	CbGeAlD
Minaprine—CYP2D6—urine—schizophrenia	0.00137	0.0197	CbGeAlD
Minaprine—MAOA—blood plasma—schizophrenia	0.0012	0.0173	CbGeAlD
Minaprine—Gefitinib—ERBB3—schizophrenia	0.00117	0.316	CrCbGaD
Minaprine—ACHE—telencephalon—schizophrenia	0.0011	0.0159	CbGeAlD
Minaprine—DRD1—forebrain—schizophrenia	0.0011	0.0159	CbGeAlD
Minaprine—Moclobemide—MAOA—schizophrenia	0.00106	0.285	CrCbGaD
Minaprine—DRD1—telencephalon—schizophrenia	0.00101	0.0146	CbGeAlD
Minaprine—HTR2C—forebrain—schizophrenia	0.000855	0.0123	CbGeAlD
Minaprine—SLC6A4—forebrain—schizophrenia	0.000811	0.0117	CbGeAlD
Minaprine—CHRM1—forebrain—schizophrenia	0.000808	0.0117	CbGeAlD
Minaprine—HTR2B—forebrain—schizophrenia	0.000803	0.0116	CbGeAlD
Minaprine—ACHE—midbrain—schizophrenia	0.000793	0.0114	CbGeAlD
Minaprine—HTR2C—telencephalon—schizophrenia	0.000786	0.0114	CbGeAlD
Minaprine—HTR2A—blood plasma—schizophrenia	0.000783	0.0113	CbGeAlD
Minaprine—SLC6A4—telencephalon—schizophrenia	0.000746	0.0108	CbGeAlD
Minaprine—CHRM1—telencephalon—schizophrenia	0.000743	0.0107	CbGeAlD
Minaprine—HTR2B—telencephalon—schizophrenia	0.000739	0.0107	CbGeAlD
Minaprine—DRD1—midbrain—schizophrenia	0.000727	0.0105	CbGeAlD
Minaprine—CYP2D6—blood plasma—schizophrenia	0.000713	0.0103	CbGeAlD
Minaprine—MAOA—forebrain—schizophrenia	0.000658	0.00949	CbGeAlD
Minaprine—DRD2—forebrain—schizophrenia	0.00065	0.00939	CbGeAlD
Minaprine—Moclobemide—CYP1A2—schizophrenia	0.00062	0.167	CrCbGaD
Minaprine—ACHE—cerebellum—schizophrenia	0.000613	0.00885	CbGeAlD
Minaprine—MAOA—telencephalon—schizophrenia	0.000605	0.00873	CbGeAlD
Minaprine—DRD2—telencephalon—schizophrenia	0.000598	0.00863	CbGeAlD
Minaprine—DRD1—nervous system—schizophrenia	0.000598	0.00863	CbGeAlD
Minaprine—DRD1—central nervous system—schizophrenia	0.000575	0.0083	CbGeAlD
Minaprine—HTR2C—midbrain—schizophrenia	0.000565	0.00815	CbGeAlD
Minaprine—SLC6A4—blood—schizophrenia	0.000542	0.00783	CbGeAlD
Minaprine—HTR2B—blood—schizophrenia	0.000537	0.00775	CbGeAlD
Minaprine—SLC6A4—midbrain—schizophrenia	0.000535	0.00773	CbGeAlD
Minaprine—ACHE—brain—schizophrenia	0.000498	0.00719	CbGeAlD
Minaprine—Moclobemide—CYP2D6—schizophrenia	0.000478	0.129	CrCbGaD
Minaprine—SLC6A4—endocrine gland—schizophrenia	0.00047	0.00679	CbGeAlD
Minaprine—CHRM1—endocrine gland—schizophrenia	0.000468	0.00676	CbGeAlD
Minaprine—HTR2C—nervous system—schizophrenia	0.000464	0.0067	CbGeAlD
Minaprine—DRD1—brain—schizophrenia	0.000457	0.00659	CbGeAlD
Minaprine—HTR2C—central nervous system—schizophrenia	0.000447	0.00645	CbGeAlD
Minaprine—SLC6A4—nervous system—schizophrenia	0.00044	0.00635	CbGeAlD
Minaprine—MAOA—blood—schizophrenia	0.00044	0.00635	CbGeAlD
Minaprine—CHRM1—nervous system—schizophrenia	0.000438	0.00633	CbGeAlD
Minaprine—HTR2B—nervous system—schizophrenia	0.000436	0.00629	CbGeAlD
Minaprine—MAOA—midbrain—schizophrenia	0.000434	0.00627	CbGeAlD
Minaprine—DRD2—midbrain—schizophrenia	0.00043	0.0062	CbGeAlD
Minaprine—HTR2A—forebrain—schizophrenia	0.000429	0.00619	CbGeAlD
Minaprine—SLC6A4—central nervous system—schizophrenia	0.000424	0.00612	CbGeAlD
Minaprine—CHRM1—central nervous system—schizophrenia	0.000422	0.00609	CbGeAlD
Minaprine—HTR2B—central nervous system—schizophrenia	0.00042	0.00606	CbGeAlD
Minaprine—HTR2A—telencephalon—schizophrenia	0.000395	0.00569	CbGeAlD
Minaprine—CYP2D6—forebrain—schizophrenia	0.000391	0.00564	CbGeAlD
Minaprine—MAOA—endocrine gland—schizophrenia	0.000381	0.00551	CbGeAlD
Minaprine—DRD2—endocrine gland—schizophrenia	0.000377	0.00544	CbGeAlD
Minaprine—CYP2D6—telencephalon—schizophrenia	0.000359	0.00519	CbGeAlD
Minaprine—MAOA—nervous system—schizophrenia	0.000357	0.00515	CbGeAlD
Minaprine—HTR2C—brain—schizophrenia	0.000355	0.00512	CbGeAlD
Minaprine—DRD2—nervous system—schizophrenia	0.000353	0.0051	CbGeAlD
Minaprine—MAOA—central nervous system—schizophrenia	0.000344	0.00496	CbGeAlD
Minaprine—DRD2—central nervous system—schizophrenia	0.00034	0.00491	CbGeAlD
Minaprine—SLC6A4—brain—schizophrenia	0.000336	0.00486	CbGeAlD
Minaprine—MAOA—cerebellum—schizophrenia	0.000336	0.00485	CbGeAlD
Minaprine—CHRM1—brain—schizophrenia	0.000335	0.00484	CbGeAlD
Minaprine—HTR2B—brain—schizophrenia	0.000333	0.00481	CbGeAlD
Minaprine—DRD2—cerebellum—schizophrenia	0.000332	0.0048	CbGeAlD
Minaprine—HTR2A—gonad—schizophrenia	0.000329	0.00475	CbGeAlD
Minaprine—HTR2A—blood—schizophrenia	0.000287	0.00414	CbGeAlD
Minaprine—HTR2A—midbrain—schizophrenia	0.000283	0.00409	CbGeAlD
Minaprine—MAOA—brain—schizophrenia	0.000273	0.00394	CbGeAlD
Minaprine—DRD2—brain—schizophrenia	0.00027	0.0039	CbGeAlD
Minaprine—CYP2D6—blood—schizophrenia	0.000261	0.00377	CbGeAlD
Minaprine—HTR2A—endocrine gland—schizophrenia	0.000249	0.00359	CbGeAlD
Minaprine—HTR2A—nervous system—schizophrenia	0.000233	0.00336	CbGeAlD
Minaprine—CYP2D6—endocrine gland—schizophrenia	0.000227	0.00327	CbGeAlD
Minaprine—HTR2A—central nervous system—schizophrenia	0.000224	0.00324	CbGeAlD
Minaprine—Gefitinib—CYP2D6—schizophrenia	0.000224	0.0604	CrCbGaD
Minaprine—HTR2A—cerebellum—schizophrenia	0.000219	0.00316	CbGeAlD
Minaprine—CYP2D6—nervous system—schizophrenia	0.000212	0.00306	CbGeAlD
Minaprine—CYP2D6—central nervous system—schizophrenia	0.000204	0.00295	CbGeAlD
Minaprine—CYP2D6—cerebellum—schizophrenia	0.0002	0.00288	CbGeAlD
Minaprine—HTR2A—brain—schizophrenia	0.000178	0.00257	CbGeAlD
Minaprine—CYP2D6—brain—schizophrenia	0.000162	0.00234	CbGeAlD
Minaprine—Gefitinib—ABCB1—schizophrenia	0.00016	0.0431	CrCbGaD
Minaprine—CHRM1—Signaling Pathways—TLE3—schizophrenia	9.25e-06	6.44e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PLA2G4A—schizophrenia	9.24e-06	6.44e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2C—schizophrenia	9.21e-06	6.42e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD4—schizophrenia	9.18e-06	6.4e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGA—schizophrenia	9.01e-06	6.28e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HTR2A—schizophrenia	9.01e-06	6.28e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP26B1—schizophrenia	8.98e-06	6.26e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—COMT—schizophrenia	8.96e-06	6.24e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NTRK2—schizophrenia	8.96e-06	6.24e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCK—schizophrenia	8.93e-06	6.22e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTP1—schizophrenia	8.92e-06	6.22e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD3—schizophrenia	8.92e-06	6.21e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MAOA—schizophrenia	8.9e-06	6.2e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOTCH4—schizophrenia	8.78e-06	6.12e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NPY—schizophrenia	8.78e-06	6.12e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ATP2A2—schizophrenia	8.78e-06	6.12e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCK—schizophrenia	8.78e-06	6.12e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CNR1—schizophrenia	8.77e-06	6.11e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCK—schizophrenia	8.74e-06	6.09e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PDE4B—schizophrenia	8.7e-06	6.06e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD4—schizophrenia	8.66e-06	6.03e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—EP300—schizophrenia	8.63e-06	6.01e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PDE4B—schizophrenia	8.56e-06	5.96e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCKAR—schizophrenia	8.56e-06	5.96e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD2—schizophrenia	8.55e-06	5.96e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR7—schizophrenia	8.55e-06	5.96e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PDE4B—schizophrenia	8.51e-06	5.93e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR1B—schizophrenia	8.48e-06	5.91e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—OXT—schizophrenia	8.48e-06	5.91e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—COMT—schizophrenia	8.44e-06	5.88e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ABCB1—schizophrenia	8.44e-06	5.88e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCKAR—schizophrenia	8.42e-06	5.87e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTP1—schizophrenia	8.4e-06	5.86e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCKAR—schizophrenia	8.37e-06	5.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADORA2A—schizophrenia	8.3e-06	5.78e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CNR1—schizophrenia	8.27e-06	5.76e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTM1—schizophrenia	8.2e-06	5.71e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PLA2G4A—schizophrenia	8.2e-06	5.71e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR2A—schizophrenia	8.18e-06	5.7e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADORA2A—schizophrenia	8.16e-06	5.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PLA2G4A—schizophrenia	8.16e-06	5.68e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR1A—schizophrenia	8.16e-06	5.68e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADORA2A—schizophrenia	8.12e-06	5.66e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PRL—schizophrenia	8.08e-06	5.63e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD2—schizophrenia	8.07e-06	5.62e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR7—schizophrenia	8.07e-06	5.62e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NPS—schizophrenia	8.03e-06	5.6e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PLA2G4A—schizophrenia	8.03e-06	5.59e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GCLM—schizophrenia	8.01e-06	5.58e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TPH1—schizophrenia	8.01e-06	5.58e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PLA2G4A—schizophrenia	7.99e-06	5.56e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ABCB1—schizophrenia	7.96e-06	5.54e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGA—schizophrenia	7.96e-06	5.54e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR2A—schizophrenia	7.95e-06	5.54e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD1—schizophrenia	7.88e-06	5.49e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGA—schizophrenia	7.83e-06	5.45e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGA—schizophrenia	7.79e-06	5.42e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR2A—schizophrenia	7.78e-06	5.42e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NPY—schizophrenia	7.75e-06	5.4e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ATP2A2—schizophrenia	7.75e-06	5.4e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH4—schizophrenia	7.75e-06	5.4e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PLA2G4A—schizophrenia	7.72e-06	5.38e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTM1—schizophrenia	7.72e-06	5.38e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NTRK2—schizophrenia	7.66e-06	5.34e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD3—schizophrenia	7.63e-06	5.32e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NPY—schizophrenia	7.63e-06	5.31e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ATP2A2—schizophrenia	7.63e-06	5.31e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH4—schizophrenia	7.63e-06	5.31e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PRL—schizophrenia	7.62e-06	5.31e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NPY—schizophrenia	7.59e-06	5.29e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ATP2A2—schizophrenia	7.59e-06	5.29e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH4—schizophrenia	7.59e-06	5.29e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—S100B—schizophrenia	7.53e-06	5.25e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PRKD1—schizophrenia	7.53e-06	5.25e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR1B—schizophrenia	7.48e-06	5.21e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—OXT—schizophrenia	7.48e-06	5.21e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD4—schizophrenia	7.41e-06	5.16e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR1B—schizophrenia	7.36e-06	5.13e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—OXT—schizophrenia	7.36e-06	5.13e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR1B—schizophrenia	7.32e-06	5.1e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—OXT—schizophrenia	7.32e-06	5.1e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MTHFR—schizophrenia	7.24e-06	5.05e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR2A—schizophrenia	7.22e-06	5.03e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ERBB4—schizophrenia	7.2e-06	5.02e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR1A—schizophrenia	7.2e-06	5.02e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—S100B—schizophrenia	7.1e-06	4.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NPS—schizophrenia	7.09e-06	4.94e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR1A—schizophrenia	7.08e-06	4.94e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CNR1—schizophrenia	7.07e-06	4.93e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR2A—schizophrenia	7.07e-06	4.92e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR1A—schizophrenia	7.05e-06	4.91e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NPS—schizophrenia	6.98e-06	4.86e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2C—schizophrenia	6.95e-06	4.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD1—schizophrenia	6.95e-06	4.84e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NPS—schizophrenia	6.94e-06	4.84e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD2—schizophrenia	6.9e-06	4.81e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR7—schizophrenia	6.9e-06	4.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR2C—schizophrenia	6.84e-06	4.77e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD1—schizophrenia	6.84e-06	4.77e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—MTHFR—schizophrenia	6.83e-06	4.76e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2C—schizophrenia	6.81e-06	4.74e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD1—schizophrenia	6.81e-06	4.74e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ERBB4—schizophrenia	6.79e-06	4.73e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PLA2G4A—schizophrenia	6.77e-06	4.72e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NTRK2—schizophrenia	6.76e-06	4.71e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—APOE—schizophrenia	6.74e-06	4.7e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD3—schizophrenia	6.73e-06	4.69e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—APOA1—schizophrenia	6.67e-06	4.65e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NTRK2—schizophrenia	6.66e-06	4.64e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NRG1—schizophrenia	6.64e-06	4.63e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD3—schizophrenia	6.63e-06	4.62e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NTRK2—schizophrenia	6.62e-06	4.61e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD3—schizophrenia	6.59e-06	4.59e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MEF2C—schizophrenia	6.59e-06	4.59e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD4—schizophrenia	6.54e-06	4.56e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PRL—schizophrenia	6.52e-06	4.54e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD4—schizophrenia	6.43e-06	4.48e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD4—schizophrenia	6.4e-06	4.46e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PLA2G4A—schizophrenia	6.38e-06	4.45e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—YWHAZ—schizophrenia	6.36e-06	4.43e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—APOE—schizophrenia	6.35e-06	4.43e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GAPDH—schizophrenia	6.28e-06	4.38e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—APOA1—schizophrenia	6.28e-06	4.38e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NRG1—schizophrenia	6.27e-06	4.37e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CNR1—schizophrenia	6.24e-06	4.35e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CLOCK—schizophrenia	6.23e-06	4.34e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ERBB3—schizophrenia	6.22e-06	4.34e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MEF2C—schizophrenia	6.21e-06	4.33e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CNR1—schizophrenia	6.14e-06	4.28e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CNR1—schizophrenia	6.11e-06	4.26e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR7—schizophrenia	6.09e-06	4.24e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—S100B—schizophrenia	6.07e-06	4.23e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TPH2—schizophrenia	6.07e-06	4.23e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CACNB2—schizophrenia	6.07e-06	4.23e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—YWHAZ—schizophrenia	6e-06	4.18e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD2—schizophrenia	5.99e-06	4.18e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR7—schizophrenia	5.99e-06	4.18e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR2A—schizophrenia	5.99e-06	4.17e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DPYD—schizophrenia	5.97e-06	4.16e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR7—schizophrenia	5.96e-06	4.15e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD2—schizophrenia	5.96e-06	4.15e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ERBB3—schizophrenia	5.87e-06	4.09e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB4—schizophrenia	5.81e-06	4.05e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PRL—schizophrenia	5.75e-06	4.01e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PRL—schizophrenia	5.66e-06	3.94e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2A—schizophrenia	5.65e-06	3.94e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PRL—schizophrenia	5.63e-06	3.92e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—APOE—schizophrenia	5.57e-06	3.88e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CACNA1C—schizophrenia	5.55e-06	3.87e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—APOA1—schizophrenia	5.51e-06	3.84e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	5.46e-06	3.81e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	5.41e-06	3.77e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NRG1—schizophrenia	5.36e-06	3.74e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—S100B—schizophrenia	5.36e-06	3.73e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ESR1—schizophrenia	5.32e-06	3.7e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MEF2C—schizophrenia	5.31e-06	3.7e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—S100B—schizophrenia	5.27e-06	3.67e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—APOE—schizophrenia	5.25e-06	3.66e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—S100B—schizophrenia	5.25e-06	3.66e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—APOA1—schizophrenia	5.19e-06	3.62e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	5.13e-06	3.58e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB4—schizophrenia	5.13e-06	3.57e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB4—schizophrenia	5.04e-06	3.51e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB3—schizophrenia	5.02e-06	3.5e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB4—schizophrenia	5.02e-06	3.5e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ESR1—schizophrenia	5.01e-06	3.49e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SNAP25—schizophrenia	4.85e-06	3.38e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR2A—schizophrenia	4.83e-06	3.37e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GSK3B—schizophrenia	4.82e-06	3.36e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	4.82e-06	3.36e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PLA2G4A—schizophrenia	4.74e-06	3.3e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NRG1—schizophrenia	4.73e-06	3.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PLA2G4A—schizophrenia	4.72e-06	3.29e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MEF2C—schizophrenia	4.69e-06	3.27e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NRG1—schizophrenia	4.66e-06	3.24e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NRG1—schizophrenia	4.63e-06	3.23e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MEF2C—schizophrenia	4.61e-06	3.21e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MEF2C—schizophrenia	4.59e-06	3.2e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GSK3B—schizophrenia	4.55e-06	3.17e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—YWHAZ—schizophrenia	4.53e-06	3.16e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOE—schizophrenia	4.49e-06	3.13e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—YWHAZ—schizophrenia	4.46e-06	3.11e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOA1—schizophrenia	4.44e-06	3.09e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—YWHAZ—schizophrenia	4.44e-06	3.09e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB3—schizophrenia	4.43e-06	3.09e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP1A2—schizophrenia	4.39e-06	3.06e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB3—schizophrenia	4.36e-06	3.04e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB3—schizophrenia	4.34e-06	3.02e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TH—schizophrenia	4.32e-06	3.01e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ESR1—schizophrenia	4.29e-06	2.99e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2A—schizophrenia	4.27e-06	2.97e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—schizophrenia	4.17e-06	2.91e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—schizophrenia	3.97e-06	2.76e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOA1—schizophrenia	3.92e-06	2.73e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—schizophrenia	3.9e-06	2.72e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GSK3B—schizophrenia	3.89e-06	2.71e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—schizophrenia	3.88e-06	2.7e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOA1—schizophrenia	3.86e-06	2.69e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—EP300—schizophrenia	3.84e-06	2.68e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOA1—schizophrenia	3.84e-06	2.67e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ESR1—schizophrenia	3.79e-06	2.64e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ESR1—schizophrenia	3.73e-06	2.6e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ESR1—schizophrenia	3.71e-06	2.58e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—COMT—schizophrenia	3.68e-06	2.56e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTP1—schizophrenia	3.66e-06	2.55e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MAOA—schizophrenia	3.65e-06	2.54e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—EP300—schizophrenia	3.62e-06	2.52e-05	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—schizophrenia	3.58e-06	2.49e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ABCB1—schizophrenia	3.46e-06	2.41e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GSK3B—schizophrenia	3.43e-06	2.39e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GSK3B—schizophrenia	3.38e-06	2.35e-05	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—schizophrenia	3.37e-06	2.35e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3.36e-06	2.34e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTM1—schizophrenia	3.36e-06	2.34e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GSK3B—schizophrenia	3.36e-06	2.34e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—schizophrenia	3.25e-06	2.26e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EP300—schizophrenia	3.17e-06	2.21e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—schizophrenia	3.06e-06	2.13e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EP300—schizophrenia	2.99e-06	2.09e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MTHFR—schizophrenia	2.97e-06	2.07e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	2.88e-06	2.01e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—schizophrenia	2.77e-06	1.93e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOA1—schizophrenia	2.73e-06	1.91e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—schizophrenia	2.62e-06	1.83e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EP300—schizophrenia	2.56e-06	1.78e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—schizophrenia	2.55e-06	1.77e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—schizophrenia	2.5e-06	1.75e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—schizophrenia	2.49e-06	1.74e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—schizophrenia	2.32e-06	1.62e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—schizophrenia	2.31e-06	1.61e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—schizophrenia	2.27e-06	1.58e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—schizophrenia	2.27e-06	1.58e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—schizophrenia	2.26e-06	1.58e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EP300—schizophrenia	2.26e-06	1.57e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EP300—schizophrenia	2.22e-06	1.55e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EP300—schizophrenia	2.21e-06	1.54e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—schizophrenia	2.19e-06	1.52e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—schizophrenia	2.14e-06	1.49e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—schizophrenia	1.92e-06	1.34e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—schizophrenia	1.83e-06	1.28e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—schizophrenia	1.81e-06	1.26e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—schizophrenia	1.62e-06	1.13e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—schizophrenia	1.59e-06	1.11e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—schizophrenia	1.58e-06	1.1e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—EP300—schizophrenia	1.58e-06	1.1e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—schizophrenia	1.55e-06	1.08e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—schizophrenia	1.37e-06	9.52e-06	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—schizophrenia	1.34e-06	9.36e-06	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—schizophrenia	1.34e-06	9.31e-06	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—schizophrenia	9.53e-07	6.64e-06	CbGpPWpGaD
